Consensus conference on unrelated donor BMT: Its use in leukaemias and allied disorders
1997
Unrelated Donor Bone Marrow Transplants for Leukaemias
publication
Evidence: moderate
Hypothesis
Can unrelated donor bone marrow transplants improve outcomes for patients with leukaemias?
Conclusion
Unrelated donor bone marrow transplants can lead to prolonged disease quiescence and, in some cases, eradication of leukaemia.
Supporting Evidence
- Unrelated bone marrow transplants can produce prolonged quiescence and eradication of disease in some leukaemia cases.
- Matched unrelated transplants may have similar survival rates to sibling transplants.
- Evidence suggests that early UD-BMT can yield better results for some diseases.
Takeaway
Doctors are finding that using bone marrow from unrelated donors can help some leukaemia patients get better, but it's important to match the donor carefully.
Methodology
The conclusions are based on discussions and data presented at a consensus conference.
Potential Biases
Variability in outcomes may arise from differences in how leukaemia types are defined and reported.
Limitations
There is limited data on the long-term effects and quality of life for patients receiving unrelated donor transplants.
Want to read the original?
Access the complete publication on the publisher's website